47 related articles for article (PubMed ID: 32444258)
21. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
[TBL] [Abstract][Full Text] [Related]
22. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
[TBL] [Abstract][Full Text] [Related]
23. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
Du DF; Li XL; Fang F; Du MR
Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
[TBL] [Abstract][Full Text] [Related]
24. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
25. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
[TBL] [Abstract][Full Text] [Related]
26. Endometrial expression of anti-Müllerian hormone and its type II receptor in women with polycystic ovary syndrome.
Paulson M; Sahlin L; Hirschberg AL
Reprod Biomed Online; 2020 Jul; 41(1):128-137. PubMed ID: 32444258
[TBL] [Abstract][Full Text] [Related]
27. [Anti-Mullerian hormone- its role in the pathogenesis of the polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Dimitrakova E; Malinova M; Mladenova M
Akush Ginekol (Sofiia); 2012; 51(6):22-6. PubMed ID: 23390860
[TBL] [Abstract][Full Text] [Related]
28. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.
Dewailly D; Robin G; Peigne M; Decanter C; Pigny P; Catteau-Jonard S
Hum Reprod Update; 2016 Nov; 22(6):709-724. PubMed ID: 27566840
[TBL] [Abstract][Full Text] [Related]
29. The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.
Qi X; Pang Y; Qiao J
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():82-7. PubMed ID: 26914398
[TBL] [Abstract][Full Text] [Related]
30. Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome.
Dewailly D; Barbotin AL; Dumont A; Catteau-Jonard S; Robin G
Front Endocrinol (Lausanne); 2020; 11():641. PubMed ID: 33013710
[TBL] [Abstract][Full Text] [Related]
31. Endometrial function in women with polycystic ovary syndrome: a comprehensive review.
Palomba S; Piltonen TT; Giudice LC
Hum Reprod Update; 2021 Apr; 27(3):584-618. PubMed ID: 33302299
[TBL] [Abstract][Full Text] [Related]
32. Use of anti-Müllerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome.
Aydogan Mathyk B; Cetin E; Yildiz BO
Curr Opin Endocrinol Diabetes Obes; 2022 Dec; 29(6):528-534. PubMed ID: 36218229
[TBL] [Abstract][Full Text] [Related]
33. Anti-Müllerian Hormone in Female Reproduction.
di Clemente N; Racine C; Pierre A; Taieb J
Endocr Rev; 2021 Nov; 42(6):753-782. PubMed ID: 33851994
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D and Polycystic Ovary Syndrome: a Narrative Review.
Mu Y; Cheng D; Yin TL; Yang J
Reprod Sci; 2021 Aug; 28(8):2110-2117. PubMed ID: 33113105
[TBL] [Abstract][Full Text] [Related]
35. Key signalling pathways underlying the aetiology of polycystic ovary syndrome.
Walters KA; Moreno-Asso A; Stepto NK; Pankhurst MW; Rodriguez Paris V; Rodgers RJ
J Endocrinol; 2022 Oct; 255(1):R1-R26. PubMed ID: 35980384
[TBL] [Abstract][Full Text] [Related]
36. A Narrative Review of Current Understanding of the Pathophysiology of Polycystic Ovary Syndrome: Focus on Plausible Relevance of Vitamin D.
Kalyanaraman R; Pal L
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063169
[TBL] [Abstract][Full Text] [Related]
37. Is endometrial receptivity impaired in women with polycystic ovary syndrome?
Palomba S; Falbo AI; Marci R; Caserta D
Minerva Obstet Gynecol; 2023 Apr; 75(2):172-180. PubMed ID: 35912467
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
